Ownership Summary
Quarter ending 30 Jun, 2026
Reviva Pharmaceuticals Holdings, Inc. (OTC:RVPH) has 5 institutional investors with active 13F positions as of June 2026.
- They owned 0.1% of outstanding stock in June 2026, down from 52.5% the prior quarter.
- They increased total shares held in RVPH by 650.29% quarter over quarter, and investors in Reviva Pharmaceuticals Holdings decreased 89.13% from a year ago.
- Activity in RVPH broke down as 3 buyers, 0 sellers, and 2 unchanged among 5 total holders.
- Institutional investors collectively held 7.73K shares in Reviva Pharmaceuticals Holdings as of June 2026, up by 6.7K shares quarter on quarter, and down 706.53K shares year over year.
- As of June 30, 2026, the biggest holder of Reviva Pharmaceuticals Holdings is EMC Capital Management at 6.7K shares, representing 0.05% of shares outstanding.
- The largest buyers of Reviva Pharmaceuticals Holdings for the quarter ending June 2026 were EMC Capital Management (6.7K), Mosley Wealth Management (1), Miller Global Investments, LLC (1).
- Per Business Quant, the top 5 investors in RVPH for the quarter ending June 2026 include EMC Capital Management (6.7K), TD Waterhouse Canada Inc. (625), Purpose Unlimited Inc. (405), Mosley Wealth Management (1), Miller Global Investments, LLC (1).